World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
11177
World Ranking
13262
National Ranking
5647

Jeffrey W. Taub publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Jeffrey W. Taub sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 290 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Jeffrey W. Taub D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey W. Taub sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Jeffrey W. Taub is affiliated with Wayne State University in the United States. Their research spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in the subfields of Molecular Biology, Hematology, Oncology, Genetics, and Pediatrics, Perinatology and Child Health.

The main topics covered in Taub's work include Acute Myeloid Leukemia Research, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, and Cancer therapeutics and mechanisms.

Taub has published extensively in a range of academic journals, most notably in Blood with eight publications, followed by Biochemical Pharmacology with seven, Pediatric Blood & Cancer with six, Cancer Research with four, and Signal Transduction and Targeted Therapy with two publications.

Frequent collaborators include Yubin Ge, Holly Edwards, Jenna L. Carter, Yongwei Su, and Maik Hüttemann, with which Taub has coauthored multiple papers.

Representative recent papers authored or coauthored by Taub are:

  • Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy, 2020, Signal Transduction and Targeted Therapy
  • Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia, 2020, Signal Transduction and Targeted Therapy
  • The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia, 2020, Haematologica
  • Targeting mitochondrial respiration for the treatment of acute myeloid leukemia, 2020, Biochemical Pharmacology
  • Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation, 2020, Cancers

Best Publications

  • Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

    Jeffrey E. Rubnitz;Hiroto Inaba;Gary Dahl;Raul C. Ribeiro

  • Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin.

    Jeffrey W. Taub;Xi Huang;Larry H. Matherly;Mark L. Stout

  • Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia

    Hiroto Inaba;Elaine Coustan-Smith;Xueyuan Cao;Stanley B. Pounds

  • New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.

    Eric C. Hales;Jeffrey W. Taub;Larry H. Matherly

  • Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells.

    Xiaojia Niu;Jianyun Zhao;Jun Ma;Chengzhi Xie

  • Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.

    Jeffrey W. Taub;Larry H. Matherly;Mark L. Stout;Steven A. Buck

  • The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T- cell acute lymphoblastic leukemia: A report from the Children's Oncology Group

    A Larson Gedman;Q Chen;S Kugel Desmoulin;Y Ge

  • A delicate balance - The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics.

    Tristan Knight;Daniel Luedtke;Holly Edwards;Jeffrey W Taub

  • Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL

    Qiang Wen;Benjamin Goldenson;Serena J. Silver;Monica Schenone

  • Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy

    Jenna L. Carter;Katie Hege;Jay Yang;Hasini A. Kalpage

  • Down Syndrome and Malignancies: A Unique Clinical Relationship: A Paper from the 2008 William Beaumont Hospital Symposium on Molecular Pathology

    Ana C. Xavier;Yubin Ge;Jeffrey W. Taub;Jeffrey W. Taub

  • High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia.

    Jeffrey W. Taub;Mark A. Konrad;Yubin Ge;John M. Naber

  • Down syndrome, drug metabolism and chromosome 21

    Jeffrey W. Taub;Yubin Ge

  • Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

    Maurice Labuhn;Kelly Perkins;Sören Matzk;Sören Matzk;Leila Varghese

  • Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-mutated Acute Myeloid Leukemia

    Jun Ma;Shoujing Zhao;Xinan Qiao;Tristan Knight;Tristan Knight

  • GATA1, Cytidine Deaminase, and the High Cure Rate of Down Syndrome Children With Acute Megakaryocytic Leukemia

    Yubin Ge;Mark L. Stout;Dana A. Tatman;Tanya L. Jensen

  • Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia : Relationship to immunophenotype and ploidy

    Long Zhang;Jeffrey W. Taub;Michael Williamson;So C. Wong

  • Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells

    Daniel A Luedtke;Xiaojia Niu;Yihang Pan;Jianyun Zhao;Jianyun Zhao

  • Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome

    Jeffrey W. Taub;Gina Mundschau;Yubin Ge;Janet M. Poulik

  • Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia

    Yubin Ge;Alan A. Dombkowski;Katherine M. LaFiura;Dana Tatman

Frequent Co-Authors

Larry H. Matherly
Larry H. Matherly Wayne State University
Jeffrey E. Rubnitz
Jeffrey E. Rubnitz St. Jude Children's Research Hospital
Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
Terrance L. Albrecht
Terrance L. Albrecht Wayne State University
Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
John D. Crispino
John D. Crispino Northwestern University
Elaine Coustan-Smith
Elaine Coustan-Smith National University of Singapore
Louis A. Penner
Louis A. Penner Wayne State University
Sean Phipps
Sean Phipps St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Biology and Biochemistry opens diverse career options in healthcare, research, and nutrition. Many students seek flexible programs that fit busy schedules and provide a fast track to in-demand professions.

For advanced practitioners, the fastest post master's pmhnp programs provide a quick pathway to become a Psychiatric Mental Health Nurse Practitioner, helping address the growing demand in mental health services. Similarly, nurses aiming to specialize in family practice may benefit from a 12-month fnp program online, offering speed and flexibility for career advancement.

If nutrition and wellness are your focus, pursuing one of the cheapest online nutrition degree programs can be a cost-effective step toward a rewarding nutritionist or dietitian role. Nurses with an associate degree often look to expand their opportunities through rn to bsn online programs, which deliver a streamlined path to a Bachelor of Science in Nursing.

Whether your goal is clinical practice, research, or wellness, there are online courses and degree options to suit your ambitions and budget.

Best Scientists Citing Jeffrey W. Taub

Trending Scientists

Recently Published Articles